Many patients who stop taking it tend to gain back weight or lose the health benefits they had achieved
For type 2 diabetes, tirzepatide starts at 2.5 mg subcutaneously once weekly for four weeks, then increases by 2.5 mg increments every four weeks as tolerated, per the Mounjaro prescribing information
158,161,164,165 However, activating multiple receptors may lead to more complex side effects, and in some experiments, dual and triple agonists have indeed shown more severe side effects
A just wait and see approach risks losing ground on a progressive condition during the months you spend waiting
2024a, 2024b)
For example, within the book of business for Employers Health, a leading group purchasing organization for pharmacy benefits, 60 percent of clients exclude obesity drugs, 25 percent cover them after prior authorization and the remainder allow access without any restrictions